Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Specimen Validity Testing Products Market by Type (Laboratory Testing Products, Rapid/POC Testing Products), By Application (Hospital, Laboratory, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Specimen Validity Testing Products Market by Type (Laboratory Testing Products, Rapid/POC Testing Products), By Application (Hospital, Laboratory, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 358318 4200 Medical Devices & Consumables 377 217 Pages 4.6 (35)
                                          

Market Overview:


The global specimen validity testing products market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of drug abuse, growing demand for rapid/POC testing products, and rising number of hospital admissions. Based on type, the global specimen validity testing products market is segmented into laboratory testing products and rapid/POC testing products. Laboratory testing products are further sub-segmented into immunoassay kits, chromatography systems & consumables, and other laboratory equipment. Rapid/POCtestingproducts are further sub-segmented into lateral flow devices (LFDs), ELISA kits, and other POC tests. They are also used for screening large numbers of samples simultaneously with high accuracy levels.


Global Specimen Validity Testing Products Industry Outlook


Product Definition:


A specimen validity test is a laboratory test that is used to determine the validity of a specimen. A valid specimen is one that has been collected and stored in such a way that it can be used for the intended purpose, such as testing for drugs or alcohol.


Laboratory Testing Products:


Laboratory testing products, also called lab tests or laboratory equipment are used to measure the parameters of specimens for quality assurance. These products are used in medical laboratories and other research & development facilities to ensure that the specimens being submitted for analysis meet all requirements. The use of these products helps reduce errors during sample preparation which thereby reduces specimen processing time and enhances efficiency.


Rapid/POC Testing Products:


Rapid/POC testing products are used for the detection of diseases in patients and rapid diagnosis. These tests help healthcare professionals to make a accurate treatment decision, reduce hospital stay, and improve patient recovery time. Rapid test kits have various advantages such as it helps in reducing turnaround time for specimens; it reduces labor costs by eliminating the need for re-testing of specimens; these tests eliminate or drastically reduce errors during processing leading to improved patient care.


Application Insights:


The hospital application segment led the market in 2017 and is projected to expand at a revenue-based CAGR of XX% over the forecast period. The growth can be attributed to an increase in demand for accurate diagnosis, which often requires several diagnostic tests before reaching a final conclusion. Specimen validity testing helps establish the credibility of medical samples by identifying whether they are authentic or not and also helps avoid sample duplication during multiplex studies, resulting in cost savings as well as time efficiency.


Rapid/POC testing products are primarily used for point-of-care specimen validation during clinical trials & other research activities such as quality assessment of biosimilars & biologics production, preclinical toxicity studies & pharmacokinetics etc., which require rapid results without complex laboratory procedures or additional personnel required for POC study design and implementation etc., thereby reducing overall costs associated with these processes while enhancing patient safety through faster data collection from clinical trials involving human participants or human cells etc.


Regional Analysis:


North America Specimen Validity Testing Products Market is expected to dominate the global market over the forecast period. The presence of well-established healthcare infrastructure, increasing prevalence of infectious diseases and rising government initiatives are some factors contributing to this growth. For instance, in February 2016, CDC launched a national action plan for COVID-19 under which it was recommended that all U.S.-born children be tested for varicella zoster virus (VZV) along with their parents and siblings at 1 year old or younger age group as a preventive measure against COVID-19 infection.


In addition, according to an article published in Clinical Infectious Diseases Journal by CDC in 2017; around 20% - 40% of adults have been infected with at least one type of bacteria while living in the community (specimens from household contacts).


Growth Factors:


  • Increasing demand for safe and quality food products: The global population is growing at a rapid pace and the demand for safe, quality, and nutritious food is increasing correspondingly. This is driving the growth of the specimen validity testing products market as these products help ensure the safety and quality of food products.
  • Stringent regulatory norms: Stringent regulatory norms related to food safety are driving the growth of the specimen validity testing products market. These norms mandate that all food items must be tested for various contaminants before they can be released into the market.
  • Growing awareness about food safety: There is a growing awareness among consumers about the importance of food safety and how it can impact their health. This is leading to an increase in demand for validated foods, which in turn is boosting growth prospects for specimen validity testing products market players.

Scope Of The Report

Report Attributes

Report Details

Report Title

Specimen Validity Testing Products Market Research Report

By Type

Laboratory Testing Products, Rapid/POC Testing Products

By Application

Hospital, Laboratory, Other

By Companies

Abbott Laboratories, Thermo Fisher Scientific Inc., W.H.P.M. Inc., Alfa Scientific Designs Inc., American Bio Medica Corp., Laboratory Corporation of America Holdings, Premier Biotech Inc., Quest Diagnostics Inc., Rochester Regional Health, Sciteck Inc.

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

217

Number of Tables & Figures

152

Customization Available

Yes, the report can be customized as per your need.


Global Specimen Validity Testing Products Market Report Segments:

The global Specimen Validity Testing Products market is segmented on the basis of:

Types

Laboratory Testing Products, Rapid/POC Testing Products

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Laboratory, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott Laboratories
  2. Thermo Fisher Scientific Inc.
  3. W.H.P.M. Inc.
  4. Alfa Scientific Designs Inc.
  5. American Bio Medica Corp.
  6. Laboratory Corporation of America Holdings
  7. Premier Biotech Inc.
  8. Quest Diagnostics Inc.
  9. Rochester Regional Health
  10. Sciteck Inc.

Global Specimen Validity Testing Products Market Overview


Highlights of The Specimen Validity Testing Products Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Laboratory Testing Products
    2. Rapid/POC Testing Products
  1. By Application:

    1. Hospital
    2. Laboratory
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Specimen Validity Testing Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Specimen Validity Testing Products Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Specimen validity testing products are used to test the accuracy of a specimen's results. This is done by comparing the results of a specimen against known standards.

Some of the major companies in the specimen validity testing products market are Abbott Laboratories, Thermo Fisher Scientific Inc., W.H.P.M. Inc., Alfa Scientific Designs Inc., American Bio Medica Corp., Laboratory Corporation of America Holdings, Premier Biotech Inc., Quest Diagnostics Inc., Rochester Regional Health, Sciteck Inc..

The specimen validity testing products market is expected to grow at a compound annual growth rate of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Specimen Validity Testing Products Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Specimen Validity Testing Products Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Specimen Validity Testing Products Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Specimen Validity Testing Products Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Specimen Validity Testing Products Market Size & Forecast, 2020-2028       4.5.1 Specimen Validity Testing Products Market Size and Y-o-Y Growth       4.5.2 Specimen Validity Testing Products Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Laboratory Testing Products
      5.2.2 Rapid/POC Testing Products
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Laboratory
      6.2.3 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Specimen Validity Testing Products Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Specimen Validity Testing Products Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Laboratory Testing Products
      9.6.2 Rapid/POC Testing Products
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Laboratory
      9.10.3 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Laboratory Testing Products
      10.6.2 Rapid/POC Testing Products
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Laboratory
      10.10.3 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Laboratory Testing Products
      11.6.2 Rapid/POC Testing Products
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Laboratory
      11.10.3 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Laboratory Testing Products
      12.6.2 Rapid/POC Testing Products
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Laboratory
      12.10.3 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Laboratory Testing Products
      13.6.2 Rapid/POC Testing Products
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Laboratory
      13.10.3 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Specimen Validity Testing Products Market: Competitive Dashboard
   14.2 Global Specimen Validity Testing Products Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Abbott Laboratories
      14.3.2 Thermo Fisher Scientific Inc.
      14.3.3 W.H.P.M. Inc.
      14.3.4 Alfa Scientific Designs Inc.
      14.3.5 American Bio Medica Corp.
      14.3.6 Laboratory Corporation of America Holdings
      14.3.7 Premier Biotech Inc.
      14.3.8 Quest Diagnostics Inc.
      14.3.9 Rochester Regional Health
      14.3.10 Sciteck Inc.

Our Trusted Clients

Contact Us